Smecta pore. prigot. suspension d / int. reception (strawberry) pack. 3g # 10
Category
Preparations for the gastrointestinal tract
,
Enterosorbents and antidotes
Scope of the drug
Gastrointestinal tract
Release form
Oral suspension
Manufacturer country
France
Package quantity, pcs
ten
Dosage form
Grayish-white to light grayish-yellow powder with faint strawberry odor
Structure
Composition of the preparation for 1 sachet.
Active ingredient: dioctahedral smectite 3 g
Excipients: powder for preparation of suspension for oral administration [strawberry]: strawberry flavor 0.032 g
dextrose monohydrate 0.721 g
sodium saccharinate 0.007 g
Pharmacodynamics
The drug is an aluminosilicate of natural origin, has an adsorbing effect.
It stabilizes the mucous barrier of the gastrointestinal tract, forms polyvalent bonds with mucus glycoproteins, increases its amount, improves cytoprotective properties (in relation to the negative effect of hydrogen ions of hydrochloric acid, bile salts, microorganisms and their toxins).
Possesses selective sorption properties, which are explained by its discoid-crystalline structure
adsorbs bacteria and viruses located in the lumen of the gastrointestinal tract.
In therapeutic doses, it does not affect intestinal motility.
Diosmectite is radiolucent and does not stain the stool.
Aluminum in smectite is not absorbed from the gastrointestinal tract, including in diseases of the gastrointestinal tract, accompanied by symptoms of colitis and colonopathy.
The pooled results of two double-blind, randomized trials comparing the efficacy of diosmectite versus placebo, and enrolling 602 patients aged 1 to 36 months with acute diarrhea, indicate a significant reduction in fecal excretion during the first 72 hours in the patient group. treated with diosmectitis in addition to oral rehydration.
Side effects
During clinical studies in children and adults, the following side effects have been reported.
These side effects were usually mild and transient, and mainly associated with digestive disorders.
The frequency of occurrence of adverse reactions is classified as follows: very often> 1/10, often from> 1/100 to < 1/10, infrequently from> 1/1000 to 1/100, rarely from> 1/10000 to 1/1000, very rarely from < 1/10000, including isolated reports.
Often: constipation, usually resolves with dose reduction, but in rare cases may lead to discontinuation of treatment.
Uncommon: flatulence, vomiting.
During the post-marketing experience of use, some cases of hypersensitivity reactions (frequency unknown) were reported, including urticaria, rash, pruritus and angio-edema.
Cases of exacerbation of constipation have also been reported.
Indications
In children (including infants) and adults:
Acute and chronic diarrhea (allergic, drug genesis violation of the diet and the quality of food), infectious diarrhea - as part of complex therapy.
Symptomatic treatment of heartburn, bloating, abdominal discomfort and other symptoms of dyspepsia accompanying diseases of the gastrointestinal tract.
Application during pregnancy and during breastfeeding
Pregnancy
Smecta is approved for use in pregnant and lactating women.
No dosage and regimen adjustments are required.
Contraindications
Hypersensitivity, intestinal obstruction, fructose intolerance, glucose-galactose malabsorption, sucrase isomaltase deficiency.
Carefully
It is recommended to observe an interval of 1-2 hours between taking the drug Smecta and other medicines.
Use with caution in patients with a history of severe chronic constipation.
In children with acute diarrhea, the drug should be used in conjunction with rehydration measures.
If necessary, adults can also be prescribed drug therapy in combination with rehydration measures.
A complex of measures for rehydration is prescribed depending on the course of the disease, the age and characteristics of the patient.
Drug interactions
The drug can reduce the rate and extent of absorption of drugs taken simultaneously.
It is not recommended to take the drug Smecta simultaneously with other drugs.
Influence on the ability to drive vehicles and work with mechanisms
No information available.
Dosage
Application for acute diarrhea.
Children, including infants:
- Up to 1 year: 2 sachets per day for 3 days, then - 1 sachet per day
- Older than 1 year: 4 sachets per day for 3 days, then 2 sachets per day.
Adults:
- The recommended dosage regimen is 6 sachets per day.
Application for other indications.
Children, including infants: - up to 1 year: 1 sachet per day
- 1-2 years: 1-2 sachets per day
- over 2 years old: 2-3 sachets per day.
Adults: 3 sachets per day.
The recommended course of treatment is 3-7 days.
With esophagitis, the drug Smecta should be taken orally after meals, for other indications - between meals.
A suspension should be prepared before use.
For adults, the contents of the sachet are dissolved in 1/2 glass of water, gradually adding the powder and stirring it evenly.
For children, the contents of the sachet, if necessary, are dissolved in a baby bottle (50 ml) and distributed over several doses throughout the day or mixed with any semi-liquid product (porridge, mashed potatoes, compote, baby food).
Overdose
Overdose can cause severe constipation or bezoar.
Storage conditions
The drug should be stored out of the reach of children at a temperature not exceeding 25 В° C.
Shelf life
3 years
Name ENG
SMECTA
Clinical and pharmacological group
Antidiarrheal drug with adsorbing effect
ATX code
Diosmectite
Dosage
3g x 3.76g
Structure
Composition of the preparation for 1 sachet.
Active ingredient: dioctahedral smectite 3 g Excipients: powder for preparation of suspension for oral administration [strawberry]: strawberry flavor 0.032 g
dextrose monohydrate 0.721 g
sodium saccharinate 0.007 g
Indications
In children (including infants) and adults: Acute and chronic diarrhea (allergic, drug genesis violation of the diet and the quality of food), infectious diarrhea - as part of complex therapy.
Symptomatic treatment of heartburn, bloating, abdominal discomfort and other symptoms of dyspepsia accompanying diseases of the gastrointestinal tract.
Storage conditions and periods
At a temperature not higher than 30 degrees.
Expiration date: 3 years
Contraindications
intestinal obstruction fructose intolerance, syndrome of impaired absorption of glucose-galactose deficiency of sucrase-isomaltase hypersensitivity to the components of the drug.
INN / Active ingredient
Dioctahedral smectite
Specifications
Category
Preparations for the gastrointestinal tract
,
Enterosorbents and antidotes
Scope of the drug
Gastrointestinal tract
Release form
Oral suspension
Manufacturer country
France
Package quantity, pcs
ten
Scope of application
Gastroenterology
Minimum age from
From birth
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Ipsen
The amount of the dosage form in the primary package
3.76 g
Primary packaging type
Sachet (sachet)
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antidiarrheal agent
Anatomical and therapeutic characteristics
A07BC05 Diosmectite
The target audience
Children
Expiration date in days
1095
Dosage (volume) of the substance in the preparation
1 sachet: dioctahedral smectite 3 g
Package weight, g
45
Mode of application
:
Dosage form
:
Powder for oral suspension, [strawberry]
Information on technical characteristics, delivery set, country of manufacture